ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
UroLift for Treating Lower Urinary Tract Symptoms of BPH
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 230918" data-attributes="member: 13851"><p><strong>Key Points for Decision Makers</strong></p><p></p><p><em><strong>*Since the publication of NICE MTG26, a larger body of clinical evidence has emerged, with 5-year followup, and with direct comparisons with TURP and other surgical procedures. The clinical benefts of UroLift are sustained; it is not as efficacious as TURP but is recommended by NICE as a less invasive option with fewer complications for people of age over 50 years with prostate volume of 30–80 mL </strong></em></p><p><strong></strong></p><p><strong><em>*The cost saving arising from UroLift is also sustained, under most circumstances. UroLift as a day-case procedure remains cost saving relative to TURP and HoLEP. Cost savings are uncertain when UroLift is used for treating an obstructive median lobe </em></strong></p><p><strong></strong></p><p><em><strong>*Transurethral water vapour therapy using Rezum has emerged as a comparator therapy to UroLift. It is uncertain whether UroLift is cost saving compared to Rezum</strong></em></p></blockquote><p></p>
[QUOTE="madman, post: 230918, member: 13851"] [B]Key Points for Decision Makers[/B] [I][B]*Since the publication of NICE MTG26, a larger body of clinical evidence has emerged, with 5-year followup, and with direct comparisons with TURP and other surgical procedures. The clinical benefts of UroLift are sustained; it is not as efficacious as TURP but is recommended by NICE as a less invasive option with fewer complications for people of age over 50 years with prostate volume of 30–80 mL [/B][/I] [B] [I]*The cost saving arising from UroLift is also sustained, under most circumstances. UroLift as a day-case procedure remains cost saving relative to TURP and HoLEP. Cost savings are uncertain when UroLift is used for treating an obstructive median lobe [/I] [/B] [I][B]*Transurethral water vapour therapy using Rezum has emerged as a comparator therapy to UroLift. It is uncertain whether UroLift is cost saving compared to Rezum[/B][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
UroLift for Treating Lower Urinary Tract Symptoms of BPH
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top